The Sensex and Nifty opened in red on Friday as the Nifty 50 extended its losing streak, slipping below key levels for the fifth consecutive session. The index has already given up more than half of the 1,000-point rally it had witnessed since the August 29 lows.
The Indian pharmaceutical sector supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicines in the UK. According to a government release, drug and pharmaceutical exports increased by 6.94 per cent from USD 2.35
Speaking to ANI, Associate Professor Paul Poast of the University of Chicago said, "US President Donald Trump loves tariffs. Going back to his first term, he labelled himself a tariff man. Going into this term, throughout the campaign, he kept bringing up tariffs as a policy that he was g
In a post on Truth Social, President Trump wrote, "Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America. 'IS BUILDING' will be defined as 'breaking
External Affairs Minister S Jaishankar on Thursday, without specifically mentioning the US, called out "double standard," highlighting the intricate link between international peace and global development, emphasising that both have deteriorated concurrently, impacting the Global South.
Former Ambassador V S Seshadri, speaking at IIULER Goa as part of the MEA Distinguished Lecture Series, outlined global trade challenges, highlighting US unilateral tariffs, China's economic strategies, EU protectionism, and India's limited trade share, while stressing India's four-pronged s
Former Indian Permanent Representative to the United Nations Syed Akbaruddin has criticised the US's steep H-1B visa fee hike as a "tax on trust", warning that it undermines the mutual benefits of the programme and risks eroding goodwill between India and the United States.
South Asia analyst Michael Kugelman has sharply criticised US President Donald Trump's address at the 80th session of the United Nations General Assembly, describing it as "extremely undiplomatic" and reflective of the lack of progress in India-US relations, which has seen its fair share
South Korea's Celltrion Inc. has signed an agreement to acquire Eli Lilly and Company's U.S. biopharmaceutical manufacturing facility, eliminating its tariff-related risks in the U.S. market. The purchase price was USD 330 million, as per a report by Pulse, the English service of Maeil Busi
India's Goods and Services Tax (GST) 2.0, has been hailed as a "GST booster shot" for consumption-led growth, with major reliefs announced for sectors including FMCG, MSME, textiles, automobiles, healthcare, insurance, electronics and construction, noted a report by the Union Bank of India.
Executive Director of the Observer Research Foundation (ORF) America, Dhruva Jaishankar, on Tuesday (local time) said that both Indian and US-based companies have expressed concern over the availability of sufficient skilled talent for their jobs in the wake of recent hikes in H-1B visa fees
He highlighted the surprising silence of the Indian-American diaspora on critical issues affecting India-US relations. During the meeting, a congresswoman shared that she hadn't received a single call from Indian-American voters urging policy changes, prompting Tharoor to urge the diaspor